Sutro Biopharma (STRO) Net Cash Flow (QoQ) (2018 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Net Cash Flow (QoQ) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 334.66 Mn | 170.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -509.94% |
| Sep 30, 2025 | 104.51% |
| Jun 30, 2025 | 49.80% |
| Mar 31, 2025 | -634.62% |
| Dec 31, 2024 | -81.23% |
| Sep 30, 2024 | 227.69% |
| Jun 30, 2024 | 729.03% |
| Mar 31, 2024 | 67.65% |
| Dec 31, 2023 | 91.80% |
| Sep 30, 2023 | -188.78% |
| Jun 30, 2023 | 1,034.33% |
| Mar 31, 2023 | 130.73% |
| Dec 31, 2022 | -380.37% |
| Sep 30, 2022 | -64.82% |
| Jun 30, 2022 | 3,418.84% |
| Mar 31, 2022 | -416.38% |
| Dec 31, 2021 | 98.86% |
| Sep 30, 2021 | -4,574.74% |
| Jun 30, 2021 | 100.38% |
| Mar 31, 2021 | -206.03% |